Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Other Operating Expenses (2020 - 2025)

Maravai Lifesciences Holdings has reported Other Operating Expenses over the past 6 years, most recently at $25.8 million for Q4 2025.

  • Quarterly results put Other Operating Expenses at $25.8 million for Q4 2025, up 128.9% from a year ago — trailing twelve months through Dec 2025 was $147.7 million (down 38.75% YoY), and the annual figure for FY2025 was $68.9 million, down 58.02%.
  • Other Operating Expenses for Q4 2025 was $25.8 million at Maravai Lifesciences Holdings, up from $60000.0 in the prior quarter.
  • Over the last five years, Other Operating Expenses for MRVI hit a ceiling of $154.1 million in Q3 2024 and a floor of -$117.0 million in Q4 2023.
  • Median Other Operating Expenses over the past 5 years was $37.4 million (2024), compared with a mean of $31.5 million.
  • Biggest five-year swings in Other Operating Expenses: surged 1197.2% in 2021 and later plummeted 99.96% in 2025.
  • Maravai Lifesciences Holdings' Other Operating Expenses stood at $11.2 million in 2021, then skyrocketed by 163.99% to $29.7 million in 2022, then crashed by 493.96% to -$117.0 million in 2023, then soared by 109.64% to $11.3 million in 2024, then surged by 128.9% to $25.8 million in 2025.
  • The last three reported values for Other Operating Expenses were $25.8 million (Q4 2025), $60000.0 (Q3 2025), and $70.2 million (Q2 2025) per Business Quant data.